NO963254L - Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler - Google Patents

Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler

Info

Publication number
NO963254L
NO963254L NO963254A NO963254A NO963254L NO 963254 L NO963254 L NO 963254L NO 963254 A NO963254 A NO 963254A NO 963254 A NO963254 A NO 963254A NO 963254 L NO963254 L NO 963254L
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
piperazinyl
hydroxy
phenyl
Prior art date
Application number
NO963254A
Other languages
English (en)
Norwegian (no)
Other versions
NO963254D0 (no
Inventor
Robert Allan Farr
Brent Ludvick Podlogar
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO963254D0 publication Critical patent/NO963254D0/no
Publication of NO963254L publication Critical patent/NO963254L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO963254A 1994-02-04 1996-08-02 Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler NO963254L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19208094A 1994-02-04 1994-02-04
PCT/US1994/013711 WO1995021186A1 (en) 1994-02-04 1994-11-28 Macrocyclic difluorostatone derivatives useful as antiviral agents

Publications (2)

Publication Number Publication Date
NO963254D0 NO963254D0 (no) 1996-08-02
NO963254L true NO963254L (no) 1996-08-02

Family

ID=22708156

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963254A NO963254L (no) 1994-02-04 1996-08-02 Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler

Country Status (20)

Country Link
US (1) US5969132A (de)
EP (1) EP0742791B1 (de)
JP (1) JP3574455B2 (de)
KR (1) KR100367379B1 (de)
CN (1) CN1142830A (de)
AT (1) ATE198602T1 (de)
AU (1) AU684875B2 (de)
CA (1) CA2182476C (de)
DE (1) DE69426574T2 (de)
DK (1) DK0742791T3 (de)
ES (1) ES2155515T3 (de)
FI (1) FI963073A7 (de)
GR (1) GR3035623T3 (de)
HU (1) HUT74384A (de)
IL (1) IL112514A0 (de)
NO (1) NO963254L (de)
NZ (1) NZ277410A (de)
PT (1) PT742791E (de)
WO (1) WO1995021186A1 (de)
ZA (1) ZA95756B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1633774B1 (de) 2003-06-18 2010-02-17 Tranzyme Pharma Inc. Makrozyklische motilin rezeptorantagonisten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672792A5 (de) * 1985-02-19 1989-12-29 Sandoz Ag
EP0218688B1 (de) * 1985-04-19 1990-09-12 The Upjohn Company Substituierte dihalo-statin-reninhemmungsmittel
AU3964489A (en) * 1988-07-08 1990-02-05 Smithkline Beckman Corporation Retroviral protease binding peptides
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
DK0565631T3 (da) * 1991-01-02 1996-10-07 Merrell Pharma Inc Antivirale forbindelser
WO1996002499A1 (en) * 1994-07-15 1996-02-01 Merrell Pharmaceuticals Inc. Difluorostatone antiviral agents

Also Published As

Publication number Publication date
FI963073A0 (fi) 1996-08-02
ATE198602T1 (de) 2001-01-15
FI963073L (fi) 1996-08-02
AU684875B2 (en) 1998-01-08
GR3035623T3 (en) 2001-06-29
IL112514A0 (en) 1995-05-26
JPH09508417A (ja) 1997-08-26
WO1995021186A1 (en) 1995-08-10
NO963254D0 (no) 1996-08-02
DK0742791T3 (da) 2001-04-02
EP0742791A1 (de) 1996-11-20
HU9602158D0 (en) 1996-09-30
EP0742791B1 (de) 2001-01-10
AU1262295A (en) 1995-08-21
PT742791E (pt) 2001-06-29
JP3574455B2 (ja) 2004-10-06
ZA95756B (en) 1995-10-05
DE69426574D1 (de) 2001-02-15
NZ277410A (en) 1997-02-24
HUT74384A (en) 1996-12-30
KR100367379B1 (ko) 2003-04-11
ES2155515T3 (es) 2001-05-16
DE69426574T2 (de) 2001-08-09
CA2182476C (en) 2000-12-26
FI963073A7 (fi) 1996-08-02
US5969132A (en) 1999-10-19
CN1142830A (zh) 1997-02-12

Similar Documents

Publication Publication Date Title
DE69131317D1 (de) HIV-Proteaseinhibitoren
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
CY1107626T1 (el) Παραγωγα πυραζολιου για την θεραπεια του hiv
EA200600225A1 (ru) Производные пиперазина для лечения вич инфекций
EP0885887A3 (de) Sulfonamide Inhibitore von HIV-Aspartyl Protease
AP1468A (en) Hiv inhibiting pyrimidine derivatives.
FI962022A0 (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
TR200402442T4 (tr) Pirolidin ve piperidin türevleri ve bunların nörodejeneratif bozuklukların tedavisinde kullanımları
DK297483A (da) Fremgangsmaade til fremstilling af derivater af 9-(2-hydroxyethoxymethyl)guanin
ES2165269A1 (es) Derivados de alfa-cetoamidas.
JPH02212430A (ja) ヘルペスウイルス処置用医薬組成物
ES456690A1 (es) Un procedimiento para la preparacion de nuevos derivados 1- sustituidos de 4-(diarilmetil) piperazina y de 4 (diarilme- toxi) piperidina.
EP0652011A4 (de) Prophylaktisches mittel und arzneimittel für virale erkrankungen der atemwege.
MY137468A (en) Use of biguanide derivatives to manufacturing a medicinal product with cicatrizing action
YU79693A (sh) Inhibitori hiv proteaze korisni za lečenje aidsa-a
FI962021A0 (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
NO963254L (no) Makrocykliske difluorstatonderivater som er anvendbare som antivirale midler
YU67792A (sh) Inhibitori hiv proteaze korisni za lečenje aids
DK708188D0 (da) 5- og 6-leddede heterocycliske forbindelser og farmaceutisk acceptable saltderivater heraf til anvendelse ved behandling af aids
EA199800527A1 (ru) Производнфе 2-амино-5,6-дихлорбензимидазола, обладающие противовирусной активностью
KR910010020B1 (ko) 항바이러스제
CA2195125A1 (en) Difluorostatone antiviral agents
AU7517191A (en) Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
ATE500231T1 (de) Hiv hemmende pyrimidin derivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application